{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:34:36Z","timestamp":1761514476378,"version":"build-2065373602"},"reference-count":24,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.bmcl.2019.126778","type":"journal-article","created":{"date-parts":[[2019,11,2]],"date-time":"2019-11-02T22:48:08Z","timestamp":1572734888000},"page":"126778","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["A new chemotype with promise against Trypanosoma cruzi"],"prefix":"10.1016","volume":"30","author":[{"given":"Xiaofang","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica","family":"Cal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcel","family":"Kaiser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frederick S.","family":"Buckner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Galina I.","family":"Lepesheva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Austin G.","family":"Sanford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander I.","family":"Wallick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul H.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan L.","family":"Vennerstrom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmcl.2019.126778_b0005","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1517\/17460441.2016.1160883","article-title":"Novel drug discovery for Chagas disease","volume":"11","author":"Moraes","year":"2016","journal-title":"Expert Opin Drug Discov"},{"key":"10.1016\/j.bmcl.2019.126778_b0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.actatropica.2015.12.017","article-title":"Current drug therapy and pharmaceutical challenges for Chagas disease","volume":"156","author":"Bermudez","year":"2016","journal-title":"Acta Trop"},{"key":"10.1016\/j.bmcl.2019.126778_b0015","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/nrmicro.2016.193","article-title":"Anti-trypanosomatid drug discovery: An ongoing challenge and a continuing need","volume":"15","author":"Field","year":"2017","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.bmcl.2019.126778_b0020","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1039\/C6MD00287K","article-title":"Anticancer agents interacting with membrane glucose transporters","volume":"7","author":"Granchi","year":"2016","journal-title":"Med Chem Commun"},{"key":"10.1016\/j.bmcl.2019.126778_b0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0123598","article-title":"Identification of selective inhibitors of the Plasmodium falciparum hexose transporter PfHT by screening focused libraries of anti-malarial compounds","volume":"10","author":"Ortiz","year":"2015","journal-title":"PLoS ONE"},{"unstructured":"Sutphin P, Chan D, Turcotte S, et al. Heteroaryl benzamides, compositions and methods of use. 27 January 2011, PCT WO2011011514A1.","key":"10.1016\/j.bmcl.2019.126778_b0030"},{"key":"10.1016\/j.bmcl.2019.126778_b0035","doi-asserted-by":"crossref","first-page":"94ra70","DOI":"10.1126\/scitranslmed.3002394","article-title":"Targeting GLUT1 and the Warburg effect in renal cell carcinoma by chemical synthetic lethality","volume":"3","author":"Chan","year":"2011","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.bmcl.2019.126778_b0040","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1021\/jacs.7b00059","article-title":"Chemoselective acylation of primary amines and amides with potassium acyltrifluoroborates under acidic conditions","volume":"139","author":"G\u00e1lvez","year":"2017","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.bmcl.2019.126778_b0045","doi-asserted-by":"crossref","first-page":"4717","DOI":"10.1016\/j.bmc.2004.06.023","article-title":"Synthesis and evaluation of new hydrazide derivatives as neuropeptide Y Y5 receptor antagonists for the treatment of obesity","volume":"12","author":"Juanenea","year":"2004","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmcl.2019.126778_b0050","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3390\/md8010047","article-title":"Inhibitory activity of marine sponge-derived natural products against parasitic protozoa","volume":"8","author":"Orhan","year":"2010","journal-title":"Mar Drugs"},{"key":"10.1016\/j.bmcl.2019.126778_b0055","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.parint.2017.10.010","article-title":"Novel Toxoplasma gondii inhibitor chemotypes","volume":"67","author":"Sanford","year":"2018","journal-title":"Parasitol Int"},{"key":"10.1016\/j.bmcl.2019.126778_b0060","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1021\/cb500347p","article-title":"NAMPT is the cellular target of STF-31-like small-molecule probes","volume":"9","author":"Adams","year":"2014","journal-title":"ACS Chem Biol"},{"key":"10.1016\/j.bmcl.2019.126778_b0065","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1021\/jm0100990","article-title":"ElogDoct: a tool for lipophilicity determination in drug discovery. 2. basic and neutral compounds","volume":"44","author":"Lombardo","year":"2001","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2019.126778_b0070","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1021\/ac9912247","article-title":"A high-throughput screening method for the determination of aqueous drug solubility using laser nephelometry in microtiter plates","volume":"72","author":"Bevan","year":"2000","journal-title":"Anal Chem"},{"key":"10.1016\/j.bmcl.2019.126778_b0075","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1002\/jps.10494","article-title":"Fast gradient HPLC method to determine compounds binding to human serum albumin. Relationships with octanol\/water and immobilized artificial membrane lipophilicity","volume":"92","author":"Valko","year":"2003","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.bmcl.2019.126778_b0080","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1023\/A:1012188625088","article-title":"Polar molecular surface properties predict the intestinal absorption of drugs in humans","volume":"14","author":"Palm","year":"1997","journal-title":"Pharm Res"},{"key":"10.1016\/j.bmcl.2019.126778_b0085","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1042\/bj3170353","article-title":"Hexose uptake in Trypanosoma cruzi: structure-activity relationship between substrate and transporter","volume":"317","author":"Tetaud","year":"1996","journal-title":"Biochem J"},{"key":"10.1016\/j.bmcl.2019.126778_b0090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0001736","article-title":"Diverse inhibitor chemotypes targeting Trypanosoma cruzi CYP51","volume":"6","author":"Gunatilleke","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.bmcl.2019.126778_b0095","doi-asserted-by":"crossref","first-page":"10158","DOI":"10.1021\/jm401610c","article-title":"Two analogues of fenarimol show curative activity in an experimental model of Chagas disease","volume":"56","author":"Keenan","year":"2013","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2019.126778_b0100","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.4155\/fmc.13.139","article-title":"Selection and optimization of hits from a high-throughput phenotypic screen against Trypanosoma cruzi","volume":"5","author":"Keenan","year":"2013","journal-title":"Future Med Chem"},{"key":"10.1016\/j.bmcl.2019.126778_b0105","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.ijpddr.2011.12.002","article-title":"Recent developments in sterol 14-demethylase inhibitors for Chagas disease","volume":"2","author":"Buckner","year":"2012","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"10.1016\/j.bmcl.2019.126778_b0110","doi-asserted-by":"crossref","first-page":"31602","DOI":"10.1074\/jbc.M113.497990","article-title":"Complexes of Trypanosoma cruzi sterol 14alpha-demethylase (CYP51) with two pyridine-based drug candidates for Chagas disease: structural basis for pathogen selectivity","volume":"288","author":"Hargrove","year":"2013","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmcl.2019.126778_b0115","doi-asserted-by":"crossref","first-page":"3577","DOI":"10.1074\/jbc.M510317200","article-title":"CYP51 from Trypanosoma cruzi: A phyla-specific residue in the B' helix defines substrate preferences of sterol 14alpha-demethylase","volume":"281","author":"Lepesheva","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmcl.2019.126778_b0120","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1093\/infdis\/jit042","article-title":"VNI cures acute and chronic experimental Chagas disease","volume":"208","author":"Villalta","year":"2013","journal-title":"J Infect Dis"}],"container-title":["Bioorganic & Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X19307437?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X19307437?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T07:32:08Z","timestamp":1760772728000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X19307437"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S0960894X19307437"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2019.126778","relation":{},"ISSN":["0960-894X"],"issn-type":[{"type":"print","value":"0960-894X"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A new chemotype with promise against Trypanosoma cruzi","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2019.126778","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"126778"}}